EKF Diagnostics (LON:EKF) Share Price Passes Above 200-Day Moving Average – Should You Sell?

EKF Diagnostics Holdings plc (LON:EKF) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 25.37 and traded as high as GBX 25.41. EKF Diagnostics shares last traded at GBX 24.50, with a volume of 126,978 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Stifel Nicolaus reiterated a “buy” rating and issued a GBX 35 target price on shares of EKF Diagnostics in a research report on Wednesday, April 22nd. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of GBX 35.

EKF Diagnostics Trading Down 1.2%

The firm has a market cap of £105.47 million, a P/E ratio of 52.13 and a beta of 0.53. The company has a debt-to-equity ratio of 2.01, a quick ratio of 1.77 and a current ratio of 4.16. The firm has a fifty day moving average of GBX 25.47 and a 200-day moving average of GBX 25.37.

EKF Diagnostics (LON:EKF) last announced its quarterly earnings results on Tuesday, March 24th. The company reported GBX 0.47 earnings per share (EPS) for the quarter. EKF Diagnostics had a return on equity of 3.01% and a net margin of 4.12%. Equities research analysts forecast that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current year.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.